APA (7th ed.) Citation

FE, A., ML, C., CE, F., MR, L., GW, d. L., & BM, B. (2006). Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis. Vaccine, 24(12), 2071. https://doi.org/10.1016/j.vaccine.2005.11.017

Chicago Style (17th ed.) Citation

FE, Aldwell, Cross ML, Fitzpatrick CE, Lambeth MR, de Lisle GW, and Buddle BM. "Oral Delivery of Lipid-encapsulated Mycobacterium Bovis BCG Extends Survival of the Bacillus in Vivo and Induces a Long-term Protective Immune Response Against Tuberculosis." Vaccine 24, no. 12 (2006): 2071. https://doi.org/10.1016/j.vaccine.2005.11.017.

MLA (9th ed.) Citation

FE, Aldwell, et al. "Oral Delivery of Lipid-encapsulated Mycobacterium Bovis BCG Extends Survival of the Bacillus in Vivo and Induces a Long-term Protective Immune Response Against Tuberculosis." Vaccine, vol. 24, no. 12, 2006, p. 2071, https://doi.org/10.1016/j.vaccine.2005.11.017.